FindMyKOL
Clinical trialNCT07458555Enrolling, by, invitationInterventional

The Impact of Anesthetics on FLIP

NCT07458555 is an interventional trial sponsored by Baylor Research Institute. As of 21 Nov 2026, it is enrolling by invitation only. It studies Achalasia, Esophageal, Esophagogastric Junction Outflow Obstruction and 1 more condition. The registry lists an enrollment of 30 participants at 1 site in 1 country. The registry lists a start date of 22 Nov 2024 and a primary completion date of 31 Jul 2026.

SponsorBaylor Research Institute →Enrollment30Achalasia, EsophagealEsophagogastric Junction Outflow ObstructionSpastic Esophageal Disorders
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT07458555
FieldValue
Registry IDNCT07458555
StatusEnrolling by invitation
Study typeInterventional trial
Lead sponsorBaylor Research Institute
Enrollment30
Registered sites1
Countries1
ConditionsAchalasia, Esophageal, Esophagogastric Junction Outflow Obstruction and Spastic Esophageal Disorders
Start22 Nov 2024
Primary completion31 Jul 2026
Study completion31 Jul 2026
Last update posted9 Mar 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To understand the impact of commonly used anesthetics on esophageal motility during FLIP topography.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Texas, United States1 site
  • Baylor University Medical Center - Jonsson Building

    Dallas

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 1 siteTX1FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT07458555

Each answer restates registry values shown on this page.

What is NCT07458555?

NCT07458555 is an interventional trial sponsored by Baylor Research Institute. It studies Achalasia, Esophageal, Esophagogastric Junction Outflow Obstruction and 1 more condition.

Is NCT07458555 recruiting?

As of 21 Nov 2026, it is enrolling by invitation only.

Who leads NCT07458555?

The registry names Vani A Konda, MD (principal investigator, Baylor Health Care System) as the overall official.

Where does NCT07458555 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT07458555 expected to complete?

The registry lists a primary completion date of 31 Jul 2026 and a study completion date of 31 Jul 2026. The sponsor last updated the record on 9 Mar 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.